By CATHERINE THORBECKE, ABC News(NEW YORK) -- California-based drugmaker Gilead Sciences announced its pricing plans for remdesivir, an antiviral COVID-19 drug candidate, saying the treatment will cost $520 per dose for U.S. private insurance companies and $390 per dose for... Read More.
Latest Local News
North Sound Covid-19 Vaccine Update and More
With the Covid-19 vaccine being deployed in more and ...
More Snow This Weekend – Warmup Next Week
Southern parts of the North Sound, primarily in Snohomish ...